Mint Lesion Software Recall Due to Data Linking Issue
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Mint Medical GmbH is recalling Mint Lesion software versions 3.4.0 to 3.9.5 after reports that interrupted workstation-server connections may cause data loss or incorrect patient linking.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 27, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Mint Medical GmbH initiated a voluntary recall of Mint Lesion software after determining that an interrupted connection between a workstation and the server during a read may, in rare cases, result in lost information or data incorrectly linked to other patients.
Which Products Are Affected
The recall covers Mint Lesion software versions 3.4.0 up to 3.9.5. A total of 101 systems are affected. UDI-DI codes include 04260495880341, 04260495880358, 04260495880365, 04260495880372, 04260495880389, and 04260495880396. The recall number is Z-2068-2026. Distribution includes US Nationwide and the countries of Germany, Switzerland, Austria, Belgium, Italy, France, Romania, Netherlands, United Kingdom, Spain, Czech Republic, Ireland, and Poland.
What You Should Do
Consumers should follow any instructions provided by Mint Medical GmbH regarding the affected software.
Why This Matters
The Class II recall addresses a risk of data loss or mislinking that could affect patient information accuracy during use of the diagnostic software.
Source
FDA recall Z-2068-2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,118 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 27, 2026.
Frequently Asked Questions
Common questions about this FDA recall.